Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)

Phase III Study on the Effects of Recombinant HCG Ovulation Triggering on Stimulation, Embryonic and Pregnancy Parameters in an IVF Program

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00954265

Enrollment

130

Registered

2009-08-07

Start date

2005-08-31

Completion date

2010-09-30

Last updated

2009-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryonic Development, Pregnancy, VEGF

Keywords

pregnancy occurence, OHSS

Brief summary

To access whether the ovulation triggering with rec-HCG instead urinary-HCG has any impact on the blastulation rate and pregnancy rate of patients undergoing IVF treatment

Interventions

DRUG10000 IU urinary HCG

ovulation triggering

DRUG250 mcg recombinant HCG

ovulation triggering

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 36 Years

Healthy volunteers

Inclusion criteria

* FSH\<12, * normal sperm,less than 36y, * single blastocyst transfer

Exclusion criteria

* endometriosis stage 3&4, * pco

Design outcomes

Primary

Measure	Time frame
blastulation rate	on day-5

Secondary

Measure	Time frame
pregnancy rates, VEGF levels, OHSS rate	14 days after oocyte pick up

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026